A new study raises questions about how the drug industry funnels payments to physicians and the impact of those payments on outcomes and costs.
Henry Schein's medical segment continues to grow as the distributor of healthcare supplies gains market share in large group practices, including those within health systems.
It may seem counterintuitive to hire newcomers in a field that's more complicated than ever, but experts are urging healthcare organizations to consider recruiting supply chain leaders who can apply expertise from other industries.
The healthcare supply distributor has hired Bridget Ross, a longtime Johnson & Johnson executive, to lead its growing medical segment.
Profits were relatively stable at Cardinal Health in the second quarter, but executives at the distribution giant said they are beginning to see a return to normal generic drug-pricing trends as a result of increased competition.
Profits were up at Premier, thanks to rising supply chain revenues and a recent acquisition.
When it comes to the future under President Donald Trump, leaders at group purchasing organizations agree on one thing: It's largely unclear what the new presidential administration will mean for GPOs and the vendors they contract with.
The Trump administration suggested a 20% tax on imports from Mexico could pay for a wall along the southern border aimed at stopping illegal immigration.
Two disruptors in the group purchasing sector announced growth in their membership this week. But hospitals' use of GPOs makes it hard to determine who's winning the business.
The now-completed merger of medical device giants Abbott Laboratories and St. Jude Medical will help hospitals streamline their procurement efforts, but vendor consolidation could also lead to higher supply costs.
The prices paid for X-ray systems that can be wheeled up to a surgical table or patient bed to gather images during a procedure surged this fall as providers upgraded to 3-D-compatible equipment.
Virginia prison officials have paid a secret compounding pharmacy $66,000 to obtain lethal injection drugs for its next two executions — roughly 63 times last year's going price for the state's three-drug lethal injection package.